Tatro Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$294K Hold
1,025
0.22% 63
2021
Q4
$283K Sell
1,025
-620
-38% -$157K 0.2% 69
2021
Q3
$380K Buy
1,645
+38
+2% +$9.38K 0.3% 56
2021
Q2
$369K Buy
1,607
+1
+0.1% +$201 0.25% 74
2021
Q1
$300K Buy
1,606
+73
+5% +$14.3K 0.23% 72
2020
Q4
$259K Buy
+1,533
New +$229K 0.24% 65
2020
Q3
Sell
-1,334
Closed -$219K 69
2020
Q2
$219K Buy
+1,334
New +$205K 0.31% 50

Other funds holding LLY

Tatro Capital's LLY Position: Q1 2022 in Review

Tatro Capital held its Eli Lilly (LLY) position steady in Q1 2022 at 1,025 shares worth $294K. The position accounts for 0.22% of the portfolio, ranked #63.

Tatro Capital first reported a position in LLY in Q2 2020 and has held it in 7 quarters since. The position peaked at $380K in Q3 2021. 2,343 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • Tatro Capital held 1,025 shares of Eli Lilly worth $294K as of Q1 2022.
  • Tatro Capital left its Eli Lilly share count unchanged in Q1 2022.
  • Eli Lilly made up 0.22% of Tatro Capital's portfolio in Q1 2022, its #63 holding.
  • Tatro Capital first reported a position in Eli Lilly in Q2 2020 and has held it in 7 quarters since.
  • Tatro Capital's Eli Lilly position peaked at $380K in Q3 2021.
  • 2,343 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Tatro Capital's 13F filing for Q1 2022, filed 13 May 2022.